Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Queen's Award Crowns Achievements of Local Consultancy


News provided by

Oxford PharmaGenesis

21 Apr, 2015, 16:04 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
Employees of Oxford PharmaGenesis celebrating in the sunshine at the companyâeuro(TM)s headquarters in Oxford (PRNewsFoto/Oxford PharmaGenesis)

OXFORD, England, April 21, 2015 /PRNewswire/ --

Oxfordshire-based company wins Queen's Award for Enterprise, having more than doubled its overseas sales in just 4 years.  

Oxford PharmaGenesis today celebrates winning the Queen's Award for Enterprise, for Outstanding Achievement in International Trade. This local employer is the world's first HealthScience Communications consultancy, helping its clients bring new medicines to the world in areas of patient need. Having more than doubled its exports in just 4 years, from £4.0 million in 2010 to £8.9 million in 2013, approximately 90% of its income is now earned abroad.

     (Photo: http://photos.prnewswire.com/prnh/20150421/740336 )

Sustainable growth 

Oxford PharmaGenesis has grown steadily through repeat business and personal recommendation since Dr Graham Shelton founded the company in 1998. It has expanded its Oxford headquarters into three listed barns in Tubney and opened London offices overlooking Trafalgar Square. Its 110 UK employees now work with pharmaceutical clients around the world: 65% of its business is from mainland Europe and 21% from the USA. Among its achievements, the company has supported its clients in delivering scientific symposia in South America, masterclasses in the Middle East, articles in Africa and research in Russia, and has also supported projects in China and Japan. To support its global client base, the company has already opened offices in Basel and Philadelphia, with more in the pipeline.

Pride in Oxford 

The success of Oxford PharmaGenesis upholds the enduring power of the Oxford name. Around the world, Oxford has a reputation for high standards of science and medicine, and excellence in publishing. Dr Chris Winchester, Managing Director, comments, "Oxford also means something more - an understated commitment to excellence, to getting it right for the patients, clinicians and clients we work with every day."

Talent pool 

Oxford PharmaGenesis anticipates creating further highly skilled jobs in the local area. Oxford offers an unrivalled pool of talented scientists and doctors with a flair for clear communication. It works hard to retain the talented people it recruits and develops, and clients value the continuity this approach provides. "Ours is a hugely satisfying company to work for, whose success is only made possible through the efforts of our high-performing teams," says Dr Richard White, Commercial Director and Honorary Research Associate at Oxford Brookes University.

Global growth 

As Oxford PharmaGenesis continues to grow its business around the world, Oxford will remain at the heart of the company's success. Dr Chris Winchester, Managing Director, said, "As a proudly independent company owned by Oxford-based employee shareholders, we have the freedom to make the right decisions for our company, our clients and our employees. At Oxford PharmaGenesis, we are delighted to receive this prestigious award. We are all looking forward to a visit from the Lord-Lieutenant of Oxfordshire, who will present the Grant of Appointment in June."

Notes for Editors

About the Queen's Award

  • Now in its 50th anniversary year, the Queen's Award for Enterprise is the UK's highest accolade for business success, and provides an opportunity to celebrate and encourage excellence in UK business.
  • Awards are made in three categories, International Trade, Innovation, and Sustainable Development, and are valid for 5 years.
  • Applications are made in September each year, audited by qualified accountants and considered by an Advisory Committee that includes representatives of Government, industry and commerce, and trade unions.
  • Awards are made by the Queen on the advice of the Prime Minister, and publicly announced on the Queen's birthday, 21 April.
  • Winners are invited to attend a reception at Buckingham Palace in July.
  • The Lord-Lieutenant of the County (the Queen's representative in Oxfordshire) will present a Grant of Appointment and crystal bowl at our Oxford headquarters later in the year.
  • Approximately 160 awards are made a year, with roughly 20% of applicants being successful.
  • Previous winners of a Queen's Award for International Trade include Jaguar Land Rover (2014), Hackett (2012), and the FA Premier League (2010).

About Oxford PharmaGenesis

  • Oxford PharmaGenesis Ltd is an independent consultancy established in 1998 and has 110 dedicated HealthScience experts working in offices in Oxford and London, 42 of whom are educated to PhD level or above.
  • The company's top 5 overseas markets are Switzerland (44% of total sales), USA (21%), Sweden (12%), Germany (7%) and France (2%). UK clients account for only 11% of sales.
  • Overseas sales more than doubled in four years from £4.0 million in financial year ending 31 October 2010 to £8.9 million in year ending 31 October 2013 (up 123%). Over the same period, total sales nearly doubled from £5.1 million to £10.0 million (up 95%), and employees from 63 to 108 (up 44%).
  • The company has further offices in Basel and Philadelphia which employ a further 17 people and generate in excess of an additional £2 million in sales.
  • Oxford PharmaGenesis has eight specialist practices, in medical communications, publications, value demonstration, real-world evidence, regulatory, orphan drugs, policy and commercialization.
  • It takes a leadership position by exhibiting and presenting at international meetings such as the International Society of Medical Publication Professionals, the International Publication Planning Association, the International Society for Pharmacoeconomics and Outcomes Research, the International Society of Pharmacoepidemiology and the World Orphan Drug Congress.

Further reading 

The Queen's Award for Enterprise Magazine, 2015. Available from http://www.queensawardsmagazine.com/awardwinners/search, accessed 9 April 2015

Corfield R. The small, sane voices of big pharma. Oxford Times InBusiness Magazine, 15 May 2014, page 27 Available from  http://www.oxfordtimes.co.uk/business/profiles/11210021.The_small__sane_voices_of_big_pharma/; accessed 9 April 2015.

Oxford PharmaGenesis website. http://www.pharmagenesis.com/ ; accessed 9 April 2015.

Contact 

For further information, please contact:
Dr Chris Winchester
Managing Director, Oxford PharmaGenesis
chris.winchester@pharmagenesis.com
Office: +44-(0)1865-390144
Mobile: +44-(0)7803-196998

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.